News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
More renowned speakers on the agenda for the NCI Connect and My PART webinar
Brittany Cordeiro/LinkedIn
Oct 30, 2024, 16:14

More renowned speakers on the agenda for the NCI Connect and My PART webinar

Brittany Cordeiro, Program Manager, Health Communications Specialist at National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch, posted the following on LinkedIn:

“More renowned speakers are on the agenda for the NCI Connect and My PART webinar, titled: AYA and Primary CNS Tumors: Unmet Needs and Opportunities for Collaboration.

These speakers are addressing Care and Clinical Trial Access for adolescents and young adults (AYA) with primary central nervous system (CNS) tumors. Don’t miss your opportunity to hear from Drs. Mark Gilbert, Nicole Drezner, Brigitte Widemann, and Marta Penas-Prado. REGISTER.

Wednesday, October 30, at 11 a.m. ET.

Co-hosted by National Cancer Institute (NCI) and NCI Center for Cancer Research Cancer Moonshot programs, NCI-CONNECT and MyPART.”

adolescents AYA Brittany Cordeiro Cancer research clinical trial access Dr. Brigitte Widemann Dr. Mark Gilbert Dr. Marta Penas-Prado Dr. Nicole Drezner MyPART National Cancer Institute NCIConnect OncoDaily primary CNS tumors Young Adults
Special Coverage
Blog
May 9, 2025, 10:04
Aakash Desai: AI in Predicting EGFR Mutations from Whole Slide Images in Lung Cancer
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic
Science
May 9, 2025, 07:24
Elizabeth McKenna: Study on Early- and Older-Onset Cancer Trends in the U.S. by Meredith Shiels and colleagues